Hanseatic Management Services’s West Pharmaceutical WST Stock Holding History

Hanseatic Management Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,448	Closed	-$543K	–	145
2023 Q3	$543K	Buy	1,448 +12	+0.8%	+$4.64K	1.01%	38
2023 Q2	$549K	Buy	+1,436	New	+$513K	1.01%	34
2022 Q1	–	Sell	-49	Closed	-$23K	–	188
2021 Q4	$23K	Hold	49	–	–	0.04%	92
2021 Q3	$21K	Buy	+49	New	+$20.7K	0.04%	100
2021 Q1	–	Sell	-60	Closed	-$17K	–	182
2020 Q4	$17K	Hold	60	–	–	0.04%	107
2020 Q3	$16K	Sell	60 -4,850	-99%	-$1.28M	0.04%	138
2020 Q2	$1.11M	Sell	4,910 -1,743	-26%	-$342K	0.94%	33
2020 Q1	$1.01M	Sell	6,653 -243	-4%	-$37.4K	1.08%	19
2019 Q4	$1.04M	Buy	+6,896	New	+$1M	0.95%	25
2019 Q1	–	Sell	-203	Closed	-$20K	–	317
2018 Q4	$20K	Buy	+203	New	+$22K	0.03%	158
2016 Q1	–	Sell	-14	Closed	-$1K	–	330
2015 Q4	$1K	Buy	+14	New	+$842	﹤0.01%	287

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hanseatic Management Services's WST Position: Q4 2023 in Review

Hanseatic Management Services sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 1,448 shares — an estimated $543K sold.

Hanseatic Management Services first reported a position in WST in Q4 2015 and held it in 11 quarters. The position peaked at $1.11M in Q2 2020. 782 funds tracked by Wall St. Rank hold WST as of Q4 2023.

Hanseatic Management Services reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
Hanseatic Management Services sold 1,448 West Pharmaceutical shares in Q4 2023, an estimated $543K.
Hanseatic Management Services first reported a position in West Pharmaceutical in Q4 2015 and held it in 11 quarters.
Hanseatic Management Services's West Pharmaceutical position peaked at $1.11M in Q2 2020.
782 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Hanseatic Management Services's 13F filing for Q4 2023, filed 15 Feb 2024.